Sacubitril/Valsartan vs ACE Inhibitors or ARBs

Background: Sacubitril/valsartan (SAV) is crucial for managing heart failure (HF). Randomized clinical trials have shown SAV's superiority over angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs) in reducing N-terminal pro-B-type natriuretic peptide levels....

Full description

Bibliographic Details
Main Authors: Endurance Evbayekha, MD, Abiodun Benjamin Idowu, MD, Shane LaRue, MD
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:JACC: Advances
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772963X25000158